Catalyst Event
Shanghai Junshi Biosciences Co Ltd (1877) · Earnings Release
From Akros SCHK HK-Global Genomics Index (ASHGGENM)
4/27/2026, 12:00:00 AM
Announced Q1 2026 results on April 27, 2026, reporting a 45.1% YoY increase in revenue to RMB 726 million and a significant 91.2% reduction in net loss to RMB 20.56 million. The company achieved a net profit of RMB 43.44 million after excluding share-based payment expenses.
Korean Translation
2026년 4월 27일, 2026년 1분기 실적을 발표함. 매출은 전년 동기 대비 45.1% 증가한 7억 2,600만 위안을 기록했으며, 순손실은 2,056만 위안으로 91.2% 대폭 감소함. 주식보상비용을 제외한 순이익은 4,344만 위안을 달성함.
Related Recent Events
WuXi Biologics (Cayman) Inc (2269) · Other
The U.S. Office of Management and Budget (OMB) is scheduled to publish a full list of 'biotechnology companies of concern' (BCCs) by December 18, 2026, under the BIOSECURE Act; High importance is justified by the potential for severe regulatory risk causing a >10% price impact scheduled.
12/18/2026, 12:00:00 AM
Livzon Pharmaceutical Group Inc (1513) · Other
Ex-dividend date on June 16, 2026, for the 2025 final cash dividend of RMB 14.3 per 10 shares, with payment on July 13, 2026, scheduled. This consistent dividend payout is estimated to have a minor positive impact on investor sentiment.
6/16/2026, 12:00:00 AM
Grand Pharmaceutical Group Ltd (512) · Other
Ex-dividend date for a proposed final dividend of HK$0.169 per share for the year ended December 31, 2025, on 2026-06-12 scheduled. Low importance as dividend ex-dates typically result in minor price adjustments.
6/12/2026, 12:00:00 AM
Hangzhou Tigermed Consulting Co Ltd (3347) · Other
Annual General Meeting scheduled for June 2, 2026, to vote on the 2025 profit distribution plan, a final dividend of RMB 1.26 per 10 shares, and a general mandate for the board to repurchase H-shares. Routine AGM and dividend announcement are likely to cause a price impact of 1% or more, scheduled.
6/2/2026, 12:00:00 AM
GRAIL Inc (GRAL) · Other
GRAIL to present additional data from the NHS-Galleri trial at the 2026 ASCO Annual Meeting on May 30, 2026, scheduled. High importance estimated as clinical data is a key valuation driver.
5/30/2026, 12:00:00 AM
ANTA Sports Products Limited (2020) · Other
Ex-dividend date for the final FY2025 dividend of HK$1.08 per share is scheduled for May 15, 2026.
5/15/2026, 12:00:00 AM